David Palling

Title: David Palling: Innovator in Pharmaceutical Composition

Introduction

David Palling is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of trichomoniasis. His innovative approach has the potential to improve the lives of many individuals affected by this condition.

Latest Patents

David Palling holds a patent for a method and pharmaceutical composition for treating or preventing trichomoniasis. This patent outlines a method of treating or preventing trichomoniasis infection in a subject in need thereof. The method involves administering a therapeutically effective amount of secnidazole or a pharmaceutically acceptable salt in a microgranule formulation. This formulation comprises a plurality of microgranules, which can be beneficial for subjects who may also have bacterial vaginosis, are HIV-positive, or are suffering from metronidazole-resistant or tinidazole-resistant trichomoniasis. Additionally, the microgranule formulation can be administered alongside other treatments such as paromomycin, tinidazole, metronidazole, or boric acid.

Career Highlights

David Palling is associated with Evofem Biosciences, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has led to advancements in treatments that address complex health issues.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Gregory Kaufman and Richard John Holl. These partnerships have fostered an environment of innovation and have contributed to the success of their projects.

Conclusion

David Palling's work in developing a method for treating trichomoniasis showcases his commitment to improving healthcare through innovation. His contributions to the pharmaceutical field are significant and have the potential to make a lasting impact on public health.